Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Anne Lynch

Concepts (250)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Retinopathy of Prematurity
10
2019
70
5.350
Why?
Complement Factor B
6
2019
86
2.770
Why?
Pre-Eclampsia
7
2015
152
2.280
Why?
Premature Birth
5
2017
194
2.110
Why?
Neonatal Screening
4
2018
180
1.930
Why?
Geographic Atrophy
3
2019
26
1.850
Why?
Complement Activation
5
2020
306
1.700
Why?
Birth Weight
8
2019
390
1.670
Why?
Wet Macular Degeneration
2
2019
23
1.650
Why?
Complement C3a
2
2019
36
1.340
Why?
Gestational Age
12
2019
713
1.290
Why?
Macular Degeneration
3
2020
79
1.260
Why?
Infant, Premature
5
2019
414
1.130
Why?
Pregnancy
23
2018
4800
1.020
Why?
Fetal Membranes, Premature Rupture
3
2017
37
0.980
Why?
Retinal Drusen
1
2020
8
0.930
Why?
Weight Gain
4
2019
497
0.890
Why?
Infant, Low Birth Weight
2
2017
130
0.860
Why?
Pregnancy Outcome
7
2015
334
0.840
Why?
Complement Membrane Attack Complex
1
2019
33
0.840
Why?
Infant, Newborn
12
2019
4741
0.820
Why?
Choroidal Neovascularization
1
2019
44
0.820
Why?
Visual Acuity
5
2019
217
0.780
Why?
Labor, Induced
2
2017
28
0.760
Why?
Algorithms
6
2018
1464
0.750
Why?
Abnormalities, Multiple
1
2019
181
0.730
Why?
Diagnostic Techniques, Ophthalmological
2
2018
31
0.730
Why?
Labor, Obstetric
1
2017
55
0.710
Why?
Cohort Studies
9
2019
4560
0.700
Why?
Blood Proteins
2
2015
244
0.670
Why?
Pregnancy Trimester, First
2
2015
115
0.640
Why?
Retrospective Studies
20
2020
10064
0.640
Why?
Insulin-Like Growth Factor I
1
2017
255
0.630
Why?
Bronchopulmonary Dysplasia
1
2019
273
0.620
Why?
Risk Factors
14
2019
8467
0.620
Why?
Registries
3
2019
1661
0.610
Why?
Placenta
2
2018
491
0.610
Why?
Female
46
2020
59707
0.590
Why?
Infant, Very Low Birth Weight
4
2019
64
0.580
Why?
Research Design
1
2019
834
0.560
Why?
Phacoemulsification
3
2019
62
0.540
Why?
Influenza A Virus, H1N1 Subtype
2
2012
136
0.530
Why?
Cesarean Section
3
2011
158
0.500
Why?
Body Mass Index
4
2014
2001
0.490
Why?
Humans
50
2020
104249
0.490
Why?
Colorado
7
2019
4483
0.470
Why?
Odds Ratio
5
2019
1033
0.470
Why?
Pregnancy Complications, Infectious
2
2012
255
0.460
Why?
Complement Activating Enzymes
1
2010
4
0.450
Why?
Pregnancy Complications
3
2010
471
0.440
Why?
Logistic Models
8
2019
1984
0.430
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2010
65
0.430
Why?
Influenza Vaccines
2
2012
413
0.430
Why?
Pregnant Women
1
2011
87
0.430
Why?
Inflammation
2
2018
2171
0.410
Why?
Influenza, Human
2
2012
448
0.410
Why?
Antibodies, Antiphospholipid
3
1999
26
0.380
Why?
Complement Pathway, Alternative
2
2013
125
0.380
Why?
Infant
9
2020
7629
0.370
Why?
Adult
22
2020
30359
0.370
Why?
Obesity
3
2014
2565
0.370
Why?
Receptors, Cell Surface
1
2010
390
0.360
Why?
Lens Implantation, Intraocular
2
2018
42
0.360
Why?
Enzyme-Linked Immunosorbent Assay
3
2019
915
0.350
Why?
Sensitivity and Specificity
3
2017
1912
0.350
Why?
Biomarkers
5
2020
3163
0.340
Why?
Antigens, CD
1
2010
562
0.340
Why?
Immunologic Factors
1
2008
214
0.330
Why?
Prospective Studies
10
2019
5605
0.320
Why?
Male
23
2020
58392
0.300
Why?
Aged, 80 and over
7
2020
6518
0.290
Why?
Health Knowledge, Attitudes, Practice
2
2011
1148
0.290
Why?
Case-Control Studies
6
2020
3225
0.290
Why?
Vaccination
1
2011
850
0.270
Why?
Membrane Proteins
1
2010
1049
0.270
Why?
Vitrectomy
2
2020
58
0.270
Why?
Proteomics
2
2020
708
0.260
Why?
Intraocular Pressure
3
2018
220
0.250
Why?
Tomography, Optical Coherence
2
2019
117
0.240
Why?
Multivariate Analysis
2
2019
1587
0.240
Why?
Abortion, Spontaneous
2
1999
68
0.240
Why?
Corneal Transplantation
1
2020
10
0.230
Why?
Eye Banks
1
2020
7
0.230
Why?
Aged
11
2020
18934
0.230
Why?
Strabismus
1
2020
23
0.220
Why?
Oculomotor Muscles
1
2020
38
0.220
Why?
Risk Assessment
3
2019
2934
0.220
Why?
Macula Lutea
1
2019
12
0.220
Why?
Scleral Buckling
1
2019
14
0.220
Why?
Retinal Neovascularization
1
2019
23
0.220
Why?
Vitreous Body
1
2020
92
0.210
Why?
Follow-Up Studies
5
2020
4685
0.210
Why?
Ophthalmologic Surgical Procedures
1
2020
58
0.210
Why?
Homosexuality, Male
1
2020
138
0.210
Why?
Uveitis, Posterior
1
2019
10
0.210
Why?
Retinal Detachment
1
2019
49
0.210
Why?
Diabetic Retinopathy
1
2020
144
0.210
Why?
Pilocarpine
1
2018
10
0.200
Why?
Fluorescein Angiography
1
2019
102
0.200
Why?
Estrogen Replacement Therapy
1
2019
128
0.200
Why?
Immunity, Maternally-Acquired
1
2018
25
0.200
Why?
Pregnancy Complications, Cardiovascular
1
1999
79
0.200
Why?
Ophthalmic Solutions
1
2018
61
0.190
Why?
Glaucoma, Angle-Closure
1
2018
18
0.190
Why?
Ocular Hypertension
1
2018
44
0.190
Why?
Complement System Proteins
1
2020
223
0.190
Why?
Laser Coagulation
1
2017
47
0.180
Why?
Automobile Driving
1
2018
103
0.180
Why?
Adrenergic alpha-1 Receptor Antagonists
1
2016
24
0.180
Why?
Parity
1
2017
116
0.180
Why?
Glaucoma, Open-Angle
1
2018
68
0.180
Why?
Fetus
2
2018
623
0.170
Why?
Infant, Extremely Low Birth Weight
1
2016
10
0.170
Why?
Glycoproteins
1
1999
342
0.170
Why?
United States
5
2020
11035
0.170
Why?
Cataract Extraction
1
2016
49
0.170
Why?
Glaucoma
1
2018
140
0.170
Why?
Young Adult
8
2019
10261
0.170
Why?
Recovery of Function
1
2019
571
0.160
Why?
Time-to-Pregnancy
1
2015
5
0.160
Why?
Mothers
2
2018
534
0.160
Why?
Intensive Care Units, Neonatal
1
2017
139
0.160
Why?
Ethnic Groups
1
2019
623
0.150
Why?
Risk
1
2018
952
0.150
Why?
Incidence
3
2019
2317
0.150
Why?
Self Report
1
2018
603
0.150
Why?
Proteins
1
2020
950
0.150
Why?
Obstetric Labor, Premature
1
2013
44
0.140
Why?
Cervical Ripening
1
2013
7
0.140
Why?
Sulfonamides
1
2016
382
0.140
Why?
Cervix Uteri
1
2013
43
0.130
Why?
Uterine Hemorrhage
1
2013
26
0.130
Why?
Middle Aged
10
2020
27633
0.130
Why?
Pulmonary Fibrosis
2
2008
334
0.130
Why?
Aspirin
1
2015
275
0.130
Why?
Fetal Blood
1
2013
251
0.120
Why?
Infant, Small for Gestational Age
1
2012
67
0.120
Why?
Platelet Aggregation Inhibitors
1
2015
317
0.120
Why?
Models, Statistical
1
2016
685
0.120
Why?
Autoantibodies
1
1999
1144
0.120
Why?
Phenotype
1
2019
2862
0.120
Why?
Severity of Illness Index
1
2019
2653
0.110
Why?
Hypertension
1
1999
1110
0.110
Why?
Endoglin
1
2010
14
0.110
Why?
Adiposity
1
2014
431
0.110
Why?
Cesarean Section, Repeat
1
2009
12
0.110
Why?
Cross-Sectional Studies
3
2018
3662
0.100
Why?
Placental Insufficiency
1
2010
81
0.100
Why?
Intensive Care, Neonatal
1
2009
42
0.100
Why?
Postoperative Period
2
2020
306
0.100
Why?
Health Status Disparities
1
2011
193
0.100
Why?
Pregnancy Trimester, Third
1
2008
66
0.100
Why?
Time Factors
2
2019
7066
0.100
Why?
African Continental Ancestry Group
1
2011
435
0.100
Why?
Seasons
1
2011
422
0.100
Why?
Elective Surgical Procedures
1
2009
160
0.090
Why?
Heart Rate
1
2012
818
0.090
Why?
Postoperative Complications
1
2019
2086
0.090
Why?
Models, Biological
1
2016
1842
0.090
Why?
ROC Curve
2
2019
470
0.090
Why?
Glyburide
1
2006
43
0.080
Why?
Patient Compliance
1
2011
601
0.080
Why?
Resuscitation
1
2009
255
0.080
Why?
Cataract
2
2018
133
0.080
Why?
Fetal Growth Retardation
2
2012
381
0.080
Why?
Tomography, X-Ray Computed
2
2008
2264
0.080
Why?
Predictive Value of Tests
2
2008
1913
0.080
Why?
Ultrasonography, Doppler
1
2005
94
0.080
Why?
Blood Pressure
1
2012
1654
0.080
Why?
Vaginal Smears
1
2004
44
0.080
Why?
Papanicolaou Test
1
2004
42
0.080
Why?
Urban Health
1
2004
95
0.080
Why?
Pandemics
1
2011
585
0.080
Why?
Contraceptives, Oral, Combined
1
2004
18
0.070
Why?
Uterus
1
2005
181
0.070
Why?
Length of Stay
1
2009
984
0.070
Why?
Ovarian Follicle
1
2004
55
0.070
Why?
Double-Blind Method
4
2015
1609
0.070
Why?
Diabetes, Gestational
1
2006
234
0.070
Why?
Surveys and Questionnaires
3
2020
4151
0.060
Why?
Practice Guidelines as Topic
1
2011
1525
0.060
Why?
Vision, Binocular
1
2020
13
0.060
Why?
Myotomy
1
2020
12
0.060
Why?
Adolescent
5
2020
17541
0.050
Why?
Eye Movements
1
2020
80
0.050
Why?
Growth Charts
1
2019
12
0.050
Why?
Protective Factors
1
2019
76
0.050
Why?
Canada
1
2020
301
0.050
Why?
beta 2-Glycoprotein I
1
1999
6
0.050
Why?
Antibodies, Anticardiolipin
1
1999
7
0.050
Why?
Remission, Spontaneous
1
2019
40
0.050
Why?
Anthropometry
1
2019
190
0.050
Why?
Pulmonary Gas Exchange
1
1999
138
0.050
Why?
Phosphatidylserines
1
1999
70
0.050
Why?
Patient Acceptance of Health Care
1
2004
607
0.050
Why?
Positive-Pressure Respiration
1
1999
85
0.050
Why?
Area Under Curve
1
2019
343
0.050
Why?
Axial Length, Eye
1
2018
9
0.050
Why?
Corneal Pachymetry
1
2018
11
0.050
Why?
Exfoliation Syndrome
1
2018
10
0.050
Why?
Pseudophakia
1
2018
11
0.050
Why?
Tonometry, Ocular
1
2018
71
0.050
Why?
Hypoglycemic Agents
1
2006
879
0.050
Why?
Refraction, Ocular
1
2018
17
0.050
Why?
Confidence Intervals
1
1999
328
0.050
Why?
Immunoglobulin M
1
1999
264
0.050
Why?
Trabeculectomy
1
2018
49
0.050
Why?
North America
1
2018
240
0.050
Why?
Bronchodilator Agents
1
1999
225
0.050
Why?
Physical Examination
1
2019
239
0.050
Why?
Respiratory Insufficiency
1
1999
257
0.040
Why?
Interferon-beta
2
2008
96
0.040
Why?
Plethysmography
1
2014
124
0.040
Why?
Apgar Score
1
1994
15
0.040
Why?
Immunoglobulin G
1
1999
774
0.040
Why?
Respiratory Function Tests
2
2008
547
0.040
Why?
Treatment Outcome
2
2020
8608
0.040
Why?
Disease Progression
2
2013
2341
0.030
Why?
Mice
1
2010
14765
0.030
Why?
Nitric Oxide
1
1999
870
0.030
Why?
Treatment Failure
2
2006
328
0.030
Why?
Linear Models
1
2014
876
0.030
Why?
Organ Size
1
2013
510
0.030
Why?
Maternal-Fetal Exchange
1
2012
151
0.030
Why?
Prevalence
1
1997
2225
0.030
Why?
Adipose Tissue
1
2014
625
0.030
Why?
Socioeconomic Factors
1
2014
1152
0.030
Why?
Body Composition
1
2014
709
0.030
Why?
Child, Preschool
2
2020
9106
0.030
Why?
Antibodies, Viral
1
2012
465
0.020
Why?
Animals
1
2010
34264
0.020
Why?
Chi-Square Distribution
1
2008
573
0.020
Why?
Fetal Macrosomia
1
2006
36
0.020
Why?
Child
2
2020
15648
0.020
Why?
Chicago
1
2004
45
0.020
Why?
Rheology
1
2005
86
0.020
Why?
Ethinyl Estradiol
1
2004
13
0.020
Why?
Proportional Hazards Models
1
2008
1072
0.020
Why?
Levonorgestrel
1
2004
37
0.020
Why?
Survival Analysis
1
2008
1406
0.020
Why?
Ultrasonography, Prenatal
1
2005
228
0.020
Why?
Desogestrel
1
2004
40
0.020
Why?
Menstrual Cycle
1
2004
104
0.020
Why?
Women's Health
1
2004
250
0.020
Why?
Uterine Cervical Neoplasms
1
2004
211
0.020
Why?
Drug Administration Schedule
1
2004
838
0.020
Why?
Regression Analysis
1
2003
1158
0.010
Why?
Administration, Inhalation
1
1999
648
0.010
Why?
Oxygen
1
1999
844
0.010
Why?
Hypoxia
1
1999
908
0.010
Why?
Lynch's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2021 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)